Research findings of Danatlas' innovative drug project unveiled at AACR

Time:2024-04-12

Beijing Time 4 Month 7 Day, the 115 American Association for Cancer Research Annual Meeting (AACR, 2024) was grandly held in San Diego, USA. “Inspiring Science . Promoting Progress . Innovative Therapies” as its theme, focusing on early-stage cancer research and innovative advancements, showcasing numerous cutting-edge research findings in the field of oncology. Danatlas made its debut at the AACR Annual Meeting, presenting two significant research findings in poster format: DAT2000APARG Inhibitor / DAT1000A Polθ Inhibitor preclinical research data.

 Compressed

This conference brought together top experts and partners in the global oncology research field to share the latest advancements in cancer and related medical sciences, aiming to drive breakthroughs in cancer treatment.


 

DANATLAS US PHARMACEUTICALS, INC Office Address: 154 Wells Ave, Newton, MA 02459

business licence